NCT05838911Completed
Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training. Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscle strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 2 Apr 2023
- Start date
- 2 Apr 2023
- Primary completion date
- 13 Feb 2024
- Lead sponsor
- Beni-Suef University
- Diseases
- COPD
- NCT number
- NCT05838911
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 2 Apr 2023 to the primary completion date, 13 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Patients with unstable angina pectoris.
- Progressive ventricular dysrhythmia.
- Intermittent claudication.
- Implanted cardiac pacemakers.
- Uncontrolled diabetes mellitus.
- Peripheral vascular disease.
Who the study is looking for
- A diagnosis of COPD with FEV1/FVC \<50% predicted as per the GOLD guidelines.
- Self-reported dyspnea and/or arm fatigue during at least one activity of daily living that required arm exercise.
- Dyspnea and/or physical activity fatigue were self-reported by the Borg Scale.
- Before entering in the study, all patients had their pulmonary function optimized with long-acting bronchodilators and corticosteroids.
Age in the registry: 65 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt Coordinator of this site? Confirm its status | Qina | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.